vs

Side-by-side financial comparison of CNO Financial Group, Inc. (CNO) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.2× CNO Financial Group, Inc.). CNO Financial Group, Inc. runs the higher net margin — 8.8% vs 4.4%, a 4.4% gap on every dollar of revenue. On growth, PACS Group, Inc. posted the faster year-over-year revenue change (18.4% vs 4.2%). Over the past eight quarters, PACS Group, Inc.'s revenue compounded faster (20.5% CAGR vs -0.6%).

CNO Financial Group, Inc., formerly Conseco, Inc., is an American financial services holding company based in Carmel, Indiana. Its insurance subsidiaries provide life insurance, annuity and supplemental health insurance products to more than four million customers in the United States. These products are distributed through independent agents, career agents and direct to customers through television advertising and direct mail.

CNO vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.2× larger
PACS
$1.4B
$1.1B
CNO
Growing faster (revenue YoY)
PACS
PACS
+14.2% gap
PACS
18.4%
4.2%
CNO
Higher net margin
CNO
CNO
4.4% more per $
CNO
8.8%
4.4%
PACS
Faster 2-yr revenue CAGR
PACS
PACS
Annualised
PACS
20.5%
-0.6%
CNO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNO
CNO
PACS
PACS
Revenue
$1.1B
$1.4B
Net Profit
$100.7M
$59.7M
Gross Margin
Operating Margin
15.2%
7.0%
Net Margin
8.8%
4.4%
Revenue YoY
4.2%
18.4%
Net Profit YoY
-39.4%
3022.5%
EPS (diluted)
$1.02
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNO
CNO
PACS
PACS
Q4 25
$1.1B
$1.4B
Q3 25
$1.2B
$1.3B
Q2 25
$1.2B
$1.3B
Q1 25
$1.0B
$1.3B
Q4 24
$1.1B
$1.1B
Q3 24
$1.1B
$1.0B
Q2 24
$1.1B
$981.4M
Q1 24
$1.2B
$934.3M
Net Profit
CNO
CNO
PACS
PACS
Q4 25
$100.7M
$59.7M
Q3 25
$23.1M
$52.4M
Q2 25
$91.8M
$51.0M
Q1 25
$13.7M
$28.5M
Q4 24
$166.1M
$1.9M
Q3 24
$9.3M
$15.6M
Q2 24
$116.3M
$-10.9M
Q1 24
$112.3M
$49.1M
Gross Margin
CNO
CNO
PACS
PACS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
17.1%
Q2 24
22.3%
Q1 24
21.2%
Operating Margin
CNO
CNO
PACS
PACS
Q4 25
15.2%
7.0%
Q3 25
13.7%
6.4%
Q2 25
9.8%
6.2%
Q1 25
10.4%
3.8%
Q4 24
15.8%
1.7%
Q3 24
13.6%
2.2%
Q2 24
13.9%
0.1%
Q1 24
6.5%
8.6%
Net Margin
CNO
CNO
PACS
PACS
Q4 25
8.8%
4.4%
Q3 25
1.9%
3.9%
Q2 25
8.0%
3.9%
Q1 25
1.4%
2.2%
Q4 24
15.1%
0.2%
Q3 24
0.8%
1.5%
Q2 24
10.9%
-1.1%
Q1 24
9.7%
5.3%
EPS (diluted)
CNO
CNO
PACS
PACS
Q4 25
$1.02
$0.42
Q3 25
$0.24
$0.32
Q2 25
$0.91
$0.31
Q1 25
$0.13
$0.17
Q4 24
$1.58
$-0.03
Q3 24
$0.09
$0.10
Q2 24
$1.06
$-0.07
Q1 24
$1.01
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNO
CNO
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$197.0M
Total DebtLower is stronger
$353.2M
Stockholders' EquityBook value
$2.6B
$946.8M
Total Assets
$38.8B
$5.6B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNO
CNO
PACS
PACS
Q4 25
$197.0M
Q3 25
$355.7M
Q2 25
$294.2M
Q1 25
$287.5M
Q4 24
$157.7M
Q3 24
$49.5M
Q2 24
$73.4M
Q1 24
$81.2M
Total Debt
CNO
CNO
PACS
PACS
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CNO
CNO
PACS
PACS
Q4 25
$2.6B
$946.8M
Q3 25
$2.6B
$871.3M
Q2 25
$2.5B
$806.8M
Q1 25
$2.5B
$750.2M
Q4 24
$2.5B
$709.6M
Q3 24
$2.7B
$660.0M
Q2 24
$2.4B
$572.1M
Q1 24
$2.4B
$128.0M
Total Assets
CNO
CNO
PACS
PACS
Q4 25
$38.8B
$5.6B
Q3 25
$38.3B
$5.6B
Q2 25
$37.3B
$5.5B
Q1 25
$37.4B
$5.5B
Q4 24
$37.9B
$5.2B
Q3 24
$37.6B
$4.5B
Q2 24
$36.3B
$3.9B
Q1 24
$34.9B
$3.9B
Debt / Equity
CNO
CNO
PACS
PACS
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNO
CNO
PACS
PACS
Operating Cash FlowLast quarter
$195.7M
$-3.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.94×
-0.06×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNO
CNO
PACS
PACS
Q4 25
$195.7M
$-3.4M
Q3 25
$197.8M
$204.8M
Q2 25
$145.5M
$52.6M
Q1 25
$136.7M
$150.2M
Q4 24
$191.0M
$64.6M
Q3 24
$231.2M
$209.2M
Q2 24
$110.9M
$34.8M
Q1 24
$94.6M
$58.8M
Cash Conversion
CNO
CNO
PACS
PACS
Q4 25
1.94×
-0.06×
Q3 25
8.56×
3.91×
Q2 25
1.58×
1.03×
Q1 25
9.98×
5.28×
Q4 24
1.15×
33.78×
Q3 24
24.86×
13.39×
Q2 24
0.95×
Q1 24
0.84×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNO
CNO

Health Insurance Product Line$496.4M43%
Life Insurance Segment$268.8M24%
Other$207.2M18%
Life And Annuity Insurance Product Line$170.7M15%

PACS
PACS

Segment breakdown not available.

Related Comparisons